APA (7th ed.) Citation

Y, K., Y, K., Y, M., T, S., S, N., M, M., . . . A, G. (2021). Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Kato, et al. Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press, 2021.

MLA (8th ed.) Citation

Y, Kato, et al. Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press, 2021.